Mona Omar Mohsen, DPhilThe Jenner Institute, Nuffield Department of Medicine
University of Oxford
Sponsored by QRLP (Qatar Research Leadership Program)-Qatar Foundation
Talk Title
(Mutated as well as germ-line epitopes contribute to preclinical efficacy of virus-like particles based cancer vaccines)
Biography
Dr. Mona O. Mohsen obtained her B.Sc. and M.Sc. degree in biomedical science from Qatar University (2015). She received a graduate student award at Qatar University Annual Research Forum (2015). She completed an intensive summer internship at MD Anderson-Texas (2015) as well as a one year program (cancer biology and therapeutic approaches) at Harvard Medical School (2016-2017). She has pursued her DPhil studies at the University of Oxford under QRLP (Qatar Research Leadership Program) sponsorship. She received her DPhil degree in clinical medicine from the University of Oxford, UK (2018).
Dr. Mona O. Mohsen has recently been awarded a PDRA grant (postdoctoral research award) from Qatar National Research Fund as a collaboration between the National Center for Cancer Care and Research (NCCCR), a member of Hamad Medical Corporation (HMC) in Qatar and the University of Oxford for developing a novel personalized breast-cancer vaccine based on virus-like particles by incorporating tumor-specific T-cell epitopes.
During her DPhil studies, she has received funding from Allergy Therapeutics (UK Company) to investigate the effect of novel adjuvants in combination with VLP-based vaccines in melanoma murine models. She is also an academic visitor at the University of Bern – Switzerland.
